Related Experiment Video
Updated: Apr 27, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Advance preferences regarding thrombolysis in patients at risk for stroke: a cross-sectional study
T Ó Flatharta1, A Khan1, T Walsh1
1From the Department of Medicine, National University of Ireland-Galway, Department of Geriatric Medicine, Galway University Hospitals and National University of Ireland, Galway, HRB Clinical Research Facility, Galway, Ireland.
Background:
It is difficult to obtain informed consent for thrombolysis in stroke patients given the emergency setting, the need for a speedy decision and the effects of neurological deficits.
Aim:
To determine the advance preferences for thrombolysis of patients at risk for stroke following discussion of the potential risks and benefits.
Design:
Cross-sectional survey.
Methods:
Data on benefits and risks of thrombolysis within 3 h and between 3 and 4.5 h after stroke were presented orally, in writing and pictorially to patients attending geriatric and stroke services in a teaching hospital with specified stroke risk factors and preferences for thrombolysis were recorded.
Results:
Of the 121 participants, 108 (89.3%; 95% confidence interval [CI] 82.4-93.7) would opt for thrombolysis within the 3-h period and 100 (82.6%; 95% CI 74.9-88.4) within the 3- to 4.5-h period after acute stroke (P = 0.04, McNemar's test for correlated proportions). Previous stroke or transient ischaemic attack was more common among those who agreed to thrombolysis (54.1% vs. 30.4%, P = 0.04) and those who opted for thrombolysis were significantly more likely to agree to have their preferences recorded and used in the event of a stroke than those who refused thrombolysis (88.8% vs. 30.4%, P = 0.002).
Conclusion:
Advance discussion of the potential risks and benefits of thrombolysis in at-risk patients may improve decision making if thrombolysis is being considered and the patient can no longer make a decision.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Hemorrhagic Stroke ll: Pathophysiology

